ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
yehudi
|
61 |
19K |
7 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
61
|
19K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Host Key Opinion Leader Event on April 3, 2024
|
|
yehudi
|
61 |
19K |
10 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
61
|
19K
|
10
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints John Han, PharmD, as VP Medical Affairs
|
|
yehudi
|
9 |
2.6K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
9
|
2.6K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Corporate Presentation - March 2024
|
|
yehudi
|
40 |
15K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
40
|
15K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Corporate Presentation - March 2024
|
|
yehudi
|
40 |
15K |
2 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
40
|
15K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Corporate Presentation - March 2024
|
|
yehudi
|
40 |
15K |
5 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
40
|
15K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Corporate Presentation - March 2024
|
|
yehudi
|
40 |
15K |
4 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
40
|
15K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Corporate Presentation - March 2024
|
|
yehudi
|
40 |
15K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
40
|
15K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Corporate Presentation - March 2024
|
|
yehudi
|
40 |
15K |
8 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
40
|
15K
|
8
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Change of Director's Interest Notice Update
|
|
yehudi
|
6 |
1.8K |
6 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
6
|
1.8K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints Arshard M Khanani as Chief Medical Advisor
|
|
yehudi
|
10 |
4.1K |
9 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
10
|
4.1K
|
9
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints Arshard M Khanani as Chief Medical Advisor
|
|
yehudi
|
10 |
4.1K |
13 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
10
|
4.1K
|
13
|
|
ASX - By Stock
|
OPT |
Re:
Prep package half-year report Dec 31, 2023 (due week of Feb 26, 2024)
|
|
yehudi
|
5 |
2.0K |
4 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
5
|
2.0K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Appoints Arshard M Khanani as Chief Medical Advisor
|
|
yehudi
|
10 |
4.1K |
7 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
10
|
4.1K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
News: OPT Opthea Completes Enrollment In First Trial With Sozinibercept
|
|
yehudi
|
2 |
803 |
5 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
2
|
803
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
yehudi
|
161 |
75K |
10 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
161
|
75K
|
10
|
|
ASX - By Stock
|
OPT |
Re:
Important milestone: 90% enrollment achieved, timeline confirmed!
|
|
yehudi
|
15 |
7.1K |
7 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
15
|
7.1K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea to Receive US$35M Commitment and Additional US$50M
|
|
yehudi
|
32 |
13K |
18 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
32
|
13K
|
18
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
yehudi
|
161 |
75K |
7 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
161
|
75K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
yehudi
|
161 |
75K |
5 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
161
|
75K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
yehudi
|
161 |
75K |
9 |
19/11/23 |
19/11/23 |
ASX - By Stock
|
161
|
75K
|
9
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea announces A$80m Capital raise
|
|
yehudi
|
73 |
33K |
6 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
73
|
33K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
yehudi
|
161 |
75K |
6 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
161
|
75K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
yehudi
|
161 |
75K |
5 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
161
|
75K
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Hang in there!!
|
|
yehudi
|
161 |
75K |
13 |
13/08/23 |
13/08/23 |
ASX - By Stock
|
161
|
75K
|
13
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Presents at the 2023 Ophthalmology Innovation Summit
|
|
yehudi
|
1 |
872 |
5 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
1
|
872
|
5
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Presents at the Jefferies 2023 Healthcare Conference
|
|
yehudi
|
30 |
14K |
8 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
30
|
14K
|
8
|
|
ASX - By Stock
|
OPT |
Re:
OPT cheaper today than in 2019 ahead of P2b
|
|
yehudi
|
37 |
14K |
6 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
37
|
14K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
OPT cheaper today than in 2019 ahead of P2b
|
|
yehudi
|
37 |
14K |
7 |
26/05/23 |
26/05/23 |
ASX - By Stock
|
37
|
14K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Half Year Accounts
|
|
yehudi
|
88 |
37K |
2 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
88
|
37K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Half Year Accounts
|
|
yehudi
|
88 |
37K |
6 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
88
|
37K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea secures up to US$170m in non-dilutive financing
|
|
yehudi
|
35 |
20K |
3 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
35
|
20K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea secures up to US$170m in non-dilutive financing
|
|
yehudi
|
35 |
20K |
3 |
26/01/23 |
26/01/23 |
ASX - By Stock
|
35
|
20K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea secures up to US$170m in non-dilutive financing
|
|
yehudi
|
35 |
20K |
8 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
35
|
20K
|
8
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea secures up to US$170m in non-dilutive financing
|
|
yehudi
|
35 |
20K |
9 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
35
|
20K
|
9
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces MST Conference call with Jason Slakter MD
|
|
yehudi
|
13 |
7.4K |
6 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
13
|
7.4K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Dr Megan Baldwin talks investing in biotechs
|
|
yehudi
|
2 |
1.7K |
6 |
29/12/22 |
29/12/22 |
ASX - By Stock
|
2
|
1.7K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces MST Conference call with Jason Slakter MD
|
|
yehudi
|
13 |
7.4K |
16 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
13
|
7.4K
|
16
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea Announces MST Conference call with Jason Slakter MD
|
|
yehudi
|
13 |
7.4K |
6 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
13
|
7.4K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Aflibercept, recent study with, 8mg , 16 wk treatment
|
|
yehudi
|
4 |
2.5K |
9 |
15/09/22 |
15/09/22 |
ASX - By Stock
|
4
|
2.5K
|
9
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea secures up to US$170m in non-dilutive financing
|
|
yehudi
|
35 |
20K |
3 |
24/08/22 |
24/08/22 |
ASX - By Stock
|
35
|
20K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea secures up to US$170m in non-dilutive financing
|
|
yehudi
|
35 |
20K |
7 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
35
|
20K
|
7
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea secures up to US$170m in non-dilutive financing
|
|
yehudi
|
35 |
20K |
2 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
35
|
20K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea secures up to US$170m in non-dilutive financing
|
|
yehudi
|
35 |
20K |
11 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
35
|
20K
|
11
|
|
ASX - By Stock
|
OPT |
Re:
News: OPT Opthea Ltd Says Offer Price For $90 Million Placement Is A$1.15 Per New Share
|
|
yehudi
|
5 |
2.6K |
10 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
5
|
2.6K
|
10
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Trading Halt
|
|
yehudi
|
31 |
13K |
4 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
31
|
13K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Trading Halt
|
|
yehudi
|
31 |
13K |
13 |
12/08/22 |
12/08/22 |
ASX - By Stock
|
31
|
13K
|
13
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea announces establishment of ATM Equity Program
|
|
yehudi
|
17 |
7.5K |
6 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
17
|
7.5K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea's OPT-302 Granted Fast-Track for wet AMD
|
|
yehudi
|
100 |
46K |
4 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
100
|
46K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Opthea's OPT-302 Granted Fast-Track for wet AMD
|
|
yehudi
|
100 |
46K |
2 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
100
|
46K
|
2
|
|